RISING PHARMA HOLDINGS INC
Overview
RISING PHARMA HOLDINGS INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering COLESTIPOL HYDROCHLORIDE (POVIDONE PREMIX); METAXALONE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances RISING PHARMA HOLDINGS INC is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
RISING PHARMA HOLDINGS INC holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- METAXALONEActive2000-10-11
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832022-04-08
Investigations of discrepancies, failures
- 4832022-04-08
Absence of Written Procedures
- 4832022-04-08
Procedures for sterile drug products
- warning_letter2019-01-04
FDA Warning Letter (drug product)
- 4832014-06-06
Sanitation--buildings not clean, free of infestation
Is this RISING PHARMA HOLDINGS INC? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.